advertisement
 

  Back to Current Daily Care News Daily Care News from 2011

Daily Care News from 2011

    28 December 2011

  1. Insulin Pump Therapy is Equally Effective and Safe in Elderly and Young Type 1 Diabetes Patients.
  2. Psychosocial family factors and glycemic control among children aged 1-15 years with type 1 diabetes: a population-based survey. Free full text available in PDF format.
  3. Determinants of quality of life in adults with type 1 and type 2 diabetes. Free full text available in PDF format.
  4. The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
  5. A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.
  6. Natural course of untreated microalbuminuria in children and adolescents with type 1 diabetes and the importance of diabetes duration and immigrant status: longitudinal analysis from the prospective nationwide German and Austrian diabetes survey DPV.

    21 December 2011

  7. Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents.
  8. Socioeconomic factors, rather than diabetes mellitus per se, contribute to an excessive use of antidepressants among young adults with childhood onset type 1 diabetes mellitus: a register-based study.

    14 December 2011

  9. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.
  10. Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms.
  11. The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in Type 1 diabetes.
  12. Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes.
  13. Transitions in care: support group for young adults with Type 1 diabetes.
  14. Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report. Free full text available in PDF format.
  15. Cardiac function in 7-8-year-old offspring of women with type 1 diabetes. Free full text available in HTML and PDF formats.

    7 December 2011

  16. The management of diabetic ketoacidosis in children. Free full text available in HTML and PDF formats.
  17. High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes.
  18. Insulin analogues and severe hypoglycaemia in type 1 diabetes.
  19. Health-Related Quality of Life and Treatment Satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) Trial.
  20. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria.
  21. Impact of Type 1 Diabetes Mellitus on the Family is Reduced with the Medical Home, Care Coordination, and Family-Centered Care.
  22. High Prevalence of Hirsutism and Menstrual Disorders in Obese Adolescent Girls and Adolescent Girls with Type 1 Diabetes Mellitus despite Different Hormonal Profiles.
  23. Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes.

    30 November 2011

  24. Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus.
  25. QTc Interval Prolongation Is Independently Associated with Severe Hypoglycemic Attacks in Type 1 Diabetes from the EURODIAB IDDM Complications Study.

    23 November 2011

  26. Impact of insulin pumps on glycaemic control in a pump-naïve paediatric regional population.
  27. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.
  28. Disordered eating behaviors in type 1 diabetic patients. Free full text available in HTML and PDF formats.

    16 November 2011

  29. Elements of metabolic control in children with type 1 diabetes before and after introduction to insulin analogues.
  30. Improved Metabolic Control in Children and Adolescents With Type 1 Diabetes.
  31. Hip Strength in Adults With Type 1 Diabetes is Associated With Age at Onset of Diabetes.
  32. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.

    9 November 2011

  33. Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis.
  34. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
  35. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus.
  36. Availability of insulin pump therapy in clinical practice.
  37. Isomaltulose Improves Glycaemia and Maintains Run Performance in Type 1 Diabetes.
  38. Accuracy of diagnosis of depression in patients with Type 1 diabetes mellitus.
  39. Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006).

    2 November 2011

  40. Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes: Role of insulin therapy and glycemic control.
  41. Accuracy of a portable glucose meter and of a Continuous Glucose Monitoring device used at home by patients with type 1 diabetes.
  42. Dental caries-associated risk factors and type 1 diabetes mellitus.
  43. Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men.

    19 October 2011

  44. Continuous Glucose Monitoring Urged in Type 1 Diabetes.
  45. Short-term use of continuous glucose monitoring system adds to glycemic control in young type 1 diabetes mellitus patients in the long run: a clinical trial.
  46. Retinopathy screening in patients with Type 1 diabetes diagnosed in young age using a Nonmydriatic Digital Stereoscopic Retinal Imaging.
  47. Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?
  48. Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons.
  49. Eating disorders and diabetic ketoacidosis in a pregnant woman with type 1 diabetes: A case report.

    12 October 2011

  50. Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review. Free full text available in PDF format.
  51. Poor numeracy skills are associated with glycaemic control in Type 1 diabetes.
  52. Using mobile phones to measure adolescent diabetes adherence.
  53. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.

    5 October 2011

  54. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.
  55. EASD: Meta-Analysis Confirms Value of CGM in Type 1 Diabetes.
  56. Improving the Estimation of Mealtime Insulin Dose in Adults With Type 1 Diabetes.
  57. Changes in nutritional state, metabolic control and treatment of type 1 diabetes in the last 20 years. Free Spanish-language full text available in HTML and PDF formats.
  58. Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based.
  59. Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with Insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.
  60. Early markers of glycaemic control in children with type 1 diabetes mellitus. Free full text available in HTML and PDF formats (PDF link on full text page).

    28 September 2011

  61. A prospective clinical pilot-trial comparing the effect of an optimized mixed diet versus a flexible low-glycemic index diet on nutrient intake and HbA(1c) levels in children with type 1 diabetes.
  62. Prevalence of Asthma and Its Association With Glycemic Control Among Youth With Diabetes.
  63. Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes.
  64. Recent Advances in the Prevention of Hypoglycemia in Type 1 Diabetes.
  65. A Pilot Study of Acute Stress Symptoms in Parents and Youth Following Diagnosis of Type I Diabetes.
  66. Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. Free full text available in HTML and PDF formats.
  67. The Use of Continuous Glucose Monitoring in Patients with Type 2 Diabetes.

    21 September 2011

  68. Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase.
  69. Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes. Free full text available in PDF format.
  70. Reducing Rates of Severe Hypoglycemia in a Population-Based Cohort of Children and Adolescents With Type 1 Diabetes Over the Decade 2000–2009.
  71. Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?.
  72. Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
  73. The potential of incretin-based therapies in type 1 diabetes.
  74. Metabolic regulation during constant moderate physical exertion in extreme conditions in Type 1 diabetes.
  75. Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with Type 1 diabetes mellitus.
  76. Opioid Receptor Blockade Improves Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes Mellitus.
  77. Complementary and alternative medicine in children with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
  78. FDA Conducting Safety Review Of Anti-Nausea Drug Zofran.

    15 September 2011

  79. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. Free full text available in HTML and PDF formats. See also Diabetes Type 1 - Alcohol Related Deaths Rise Significantly.
  80. Depleted parental psychological resources as mediators of the association of income with adherence and metabolic control.
  81. Interventions for latent autoimmune diabetes (LADA) in adults.
  82. Implications of Nocturnal Hypertension in Children and Adolescents With Type 1 Diabetes.
  83. Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency.

    7 September 2011

  84. Treatment of type 1 diabetes in children and adolescents using modern insulin pumps.
  85. Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control.
  86. Influence of Physical Activity on Metabolic State Within a 3-h Interruption of Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes.
  87. Physical excercises on glycemic control in type 1 diabetes mellitus.
  88. Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis.
  89. Hypoglycemia unawareness.
  90. Low triglyceride levels are associated with a better metabolic control in patients with type 1 diabetes.
  91. Managing blood glucose during and after exercise in Type 1 diabetes: reproducibility of glucose response and a trial of a structured algorithm adjusting insulin and carbohydrate intake.
  92. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes.

    31 August 2011

  93. Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index).
  94. Adherence to Guidelines for Youths With Diabetes Mellitus.
  95. Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
  96. Which factors predict glycemic control in children diagnosed with type 1 diabetes before 6.5 years of age?
  97. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes.
  98. Progression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study.
  99. Willingness to Pay for Improvements in Chronic Long-Acting Insulin Therapy in Individuals With Type 1 or Type 2 Diabetes Mellitus.

    24 August 2011

  100. Does Blood Glucose Monitoring Increase Prior to Clinic Visits in Children With Type 1 Diabetes?
  101. The effectiveness of Internet-based blood glucose monitoring system on improving diabetes control in adolescents with type 1 diabetes.
  102. Behaviour and metabolic control in children with Type 1 diabetes mellitus on insulin pump therapy: 2-year follow-up.
  103. Metformin Helped My Type 1 Diabetes.
  104. Family Interaction in Pediatric Diabetes.

    17 August 2011

  105. Neurocognitive Outcomes in Young Adults With Early Onset Type 1 Diabetes.
  106. Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy.
  107. Parenting Behavior, Child Functioning, and Health Behaviors in Preadolescents with Type 1 Diabetes.
  108. Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors.

    10 August 2011

  109. Changes in Altitude Cause Unintended Insulin Delivery From Insulin Pumps: Mechanisms and implications.
  110. Non-Inferiority of Insulin Glargine Versus Insulin Detemir on Blood Glucose Variability in Type 1 Diabetes Patients: A Multicenter, Randomized, Crossover Study.
  111. High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes.

    3 August 2011

  112. Role of Parenting Style in Achieving Metabolic Control in Adolescents With Type 1 Diabetes.
  113. Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.
  114. Expert opinion and clinical experience regarding patients with type 1 diabetes mellitus fasting on Yom Kippur.

    27 July 2011

  115. The Effect of Glycemic Variability on Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents with Type 1 Diabetes.

    20 July 2011

  116. Lower cardiorespiratory fitness in children with Type 1 diabetes.
  117. Is There a Difference in Pregnancy and Glycemic Outcome in Patients with Type 1 Diabetes on Insulin Pump with Constant or Intermittent Glucose Monitoring? A Pilot Study.
  118. Glucose variability in diabetic pregnancy.
  119. Vitamin E supplementation may ameliorate oxidative stress in type 1 diabetes mellitus patients.

    13 July 2011

  120. Insulin Pump Therapy Started at the Time of Diagnosis: Effects on Glycemic Control and Pancreatic beta-Cell Function in Type 1 Diabetes.
  121. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.
  122. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
  123. Prediction of adolescents' glycemic control 1 year after diabetes-specific family conflict: the mediating role of blood glucose monitoring adherence.
  124. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. Free full text available in HTML and PDF formats.
  125. Capillary beta-hydroxybutyrate determination for monitoring diabetic ketoacidosis.
  126. Starting subcutaneous insulin doses in a paediatric population with newly diagnosed type 1 diabetes. Free full text available in HTML and PDF formats.
  127. Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study.
  128. Internet use, needs, and expectations of web-based information and communication in childbearing women with type 1 diabetes.

    29 June 2011

  129. The Low Glucose Suspend (LGS) Function in Sensor-Augmented Pump Therapy Prevents Hypoglycaemia in Children.
  130. Feasibility of Continuous Glucose Monitoring in Infants and Toddlers with Type 1 Diabetes.
  131. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes.
  132. Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control.
  133. Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetes.
  134. Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology.
  135. Diversity in diabetes: the role of insulin aspart.
  136. Optimizing the Replacement of Basal Insulin in Type 1 Diabetes Mellitus: No Longer an Elusive Goal in the Post-NPH Era.
  137. Hypoglycemia rates with Basal insulin analogs.
  138. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
  139. Parents of Children Newly Diagnosed With Type 1 Diabetes: Experiences With Social Support and Family Management.
  140. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.

    21 June 2011

  141. Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.
  142. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.
  143. Changes in nutritional state, metabolic control and treatment of type 1 diabetes in the last 20 years.
  144. Management of Exercise-Induced Glycemic Imbalances in Type 1 Diabetes.
  145. Diet, physical, and biochemical characteristics of children and adolescents with type 1 diabetes: relationship between dietary fat and glucose control.
  146. Perceptions of treatment control moderate the daily association between negative affect and diabetes problems among adolescents with type 1 diabetes.
  147. Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes.
  148. The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus.
  149. FDA Warns of Risks With Liraglutide.

    15 June 2011

  150. Youth and Parent Knowledge and Communication About Major Complications of Type 1 Diabetes: Associations With Diabetes Outcomes.
  151. Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus. Free full text available in HTML and PDF formats.

    8 June 2011

  152. Liraglutide as Additional Treatment in Type 1 Diabetes. See also Type 2 Diabetes Treatment Victoza Helps Type 1, Too.
  153. Pediatric Parenting Stress and Its Relation to Depressive Symptoms and Fear of Hypoglycemia in Parents of Young Children with Type 1 Diabetes Mellitus.
  154. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients.
  155. Quality of life in pregnancy and post-partum: a study in diabetic patients.
  156. Optimal Glycemic Control, Pre-Eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-Eclampsia Intervention Trial.
  157. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients.
  158. Effect of camel milk on glycemic control and insulin requirement in patients with type 1 diabetes: 2-years randomized controlled trial.

    1 June 2011

  159. Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine.
  160. Lipid profile and nutritional intake in children and adolescents with type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet.

    25 May 2011

  161. Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual beta-Cell Function.
  162. Preventing Exercise-Induced Hypoglycemia in Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring and a New Carbohydrate Intake Algorithm: An Observational Field Study.
  163. Insulin Detemir Reduces Weight Gain As a Result of Reduced Food Intake in Patients With Type 1 Diabetes.
  164. Developmental Trajectories of Metabolic Control among White, Black, and Hispanic Youth with Type 1 Diabetes.
  165. Incretin-based therapy in patients with type 1 diabetes mellitus.
  166. Does poor early metabolic control predict subsequent poor control in young children with Type 1 diabetes: An exploratory study.
  167. Self-management of Type 1 Diabetes Across Adolescence.
  168. The concerns of school staff in caring for children with diabetes in primary school (in the UK, ed.).
  169. Acute hypoglycemia decreases central retinal function in the human eye.
  170. Insulin resistance and hypertension in patients with type 1 diabetes.

    18 May 2011

  171. Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change.
  172. Impact of videogame playing on glucose metabolism in children with type 1 diabetes.
  173. The Effect of Recurrent Severe Hypoglycemia on Cognitive Performance in Children With Type 1 Diabetes: A Meta-analysis.
  174. Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus.

    11 May 2011

  175. A Bridge to Insulin Pump Therapy: Bid Regimen with NPH and Detemir Insulin During Initial Treatment of Youth with Type 1 Diabetes (T1D).
  176. Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes.
  177. Young adults' management of Type 1 diabetes during life transitions.
  178. A fairy tale of modern insulin therapy in type 1 diabetes.

    4 May 2011

  179. Accuracy Performance of the Medtronic NexSensorTM for 6 Days in an Inpatient Setting Using Abdomen and Buttocks Insertion Sites.
  180. Coping Skills Training for Parents of Children With Type 1 Diabetes: 12-Month Outcomes.
  181. The influence of an educational program on the HbA(1c)-level of adolescents with type 1 diabetes mellitus: a retrospective study.
  182. Age of onset of puberty and menarche in type 1 diabetic girls.

    27 April 2011

  183. Fathers' Involvement in Preadolescents' Diabetes Adherence and Glycemic Control.
  184. Vitamin D Deficiency Is Associated With Retinopathy in Children and Adolescents With Type 1 Diabetes.
  185. Retinal function in relation to improved glycaemic control in type 1 diabetes.
  186. Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol.

    20 April 2011

  187. Impaired hypoglycaemia awareness and employment in people with Type 1 diabetes.
  188. Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience.
  189. One-year variability of HbA1c in children and adolescents with type 1 diabetes - preliminary results.
  190. Persistence of Individual Variations in Glycated Hemoglobin.
  191. Serum Carotenoids and Fat-Soluble Vitamins in Women With Type 1 Diabetes and Preeclampsia: A longitudinal study.

    13 April 2011

  192. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
  193. Extraordinary exposed in early motherhood- a qualitative study exploring experiences of mothers with type 1 diabetes.
  194. Poor adherence to integral daily tasks limits the efficacy of CSII in youth.
  195. An Innovative Telemedical Support System to Measure Physical Activity in Children and Adolescents with Type 1 Diabetes Mellitus.
  196. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database.
  197. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients.
  198. Quality of life and glycemic control in adolescents with type 1 diabetes and the impact of an education intervention. Free full text available in HTML and PDF formats.
  199. Acute juvenile cataract in newly diagnosed type 1 diabetic patients: a description of six cases.
  200. Sexual Function in Women with Type 1 Diabetes Matched with a Control Group: Depressive and Psychosocial Aspects.

    6 April 2011

  201. Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial.
  202. Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.
  203. Associations Between Socioeconomic Status and Major Complications in Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complication (EDC) Study.
  204. Association of socioeconomic status with mortality in type 1 diabetes: the pittsburgh epidemiology of diabetes complications study.
  205. Effective treatment of hypoglycemia in children with type 1 diabetes: a randomized controlled clinical trial.
  206. Prescribed regimen intensity in diverse youth with type 1 diabetes: role of family and provider perceptions.
  207. The ALBA Project: an evaluation of needs, management, fears of Italian young patients with type 1 diabetes in a school setting and an evaluation of parents' and teachers' perceptions.
  208. Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: three case reports.
  209. Prevalence and Correlates of Dietary Supplement Use in Individuals With Diabetes Mellitus at an Academic Diabetes Care Clinic.

    30 March 2011

  210. Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual beta-Cell Function.
  211. Prevalence of intentional under- and overdosing of insulin in children and adolescents with type 1 diabetes.
  212. Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus.
  213. Mobile phone support is associated with reduced ketoacidosis in young adults.
  214. Attained education and self-assessed health later in life when diagnosed with diabetes in childhood: a population-based study.
  215. Association of DASH Diet With Cardiovascular Risk Factors in Youth With Diabetes Mellitus: The SEARCH for Diabetes in Youth Study.
  216. Parathormone - 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus.
  217. Cognitive function in adult offspring of women with Type 1 diabetes.
  218. Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes.

    23 March 2011

  219. Prevalence of Nocturnal Hypoglycemia in Pediatric Type 1 Diabetes: A Pilot Study Using Continuous Glucose Monitoring.
  220. Basal Insulin Requirement Is ~30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients, Who Use the Insulin Pump.
  221. Chat Line for Adolescents with Type 1 Diabetes: A Useful Tool to Improve Coping with Diabetes: A 2-Year Follow-Up Study.
  222. Parental burnout in relation to sociodemographic, psychosocial and personality factors as well as disease duration and glycaemic control in children with Type 1 diabetes mellitus.
  223. Birth Size Distribution in 3,705 Infants Born to Mothers With Type 1 Diabetes.
  224. Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria: An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort.
  225. Preliminary Application of a New Bolus Insulin Model for Type 1 Diabetes.
  226. One-Third of Patients Have Evidence for an Additional Autoimmune Disease at Type 1 Diabetes Diagnosis.

    16 March 2011

  227. Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with Type 1 diabetes mellitus.
  228. Gender differences in the relationship between parental report of self-regulation skills and adolescents' management of type 1 diabetes.
  229. Blood glucose monitoring and glycemic control in adolescents with type 1 diabetes: meter downloads versus self-report.
  230. Prediction of postprandial glycemia and insulinemia in lean, young, healthy adults: glycemic load compared with carbohydrate content alone. See also Study challenges "carb counting" in diabetes.
  231. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis.
  232. Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes.
  233. Cognitive function in 6- to 12-year-old offspring of women with Type 1 diabetes.

    9 March 2011

  234. Internet-based contingency management to improve adherence with blood glucose testing recommendations for teens with type 1 diabetes. Free full text available in HTML and PDF formats.
  235. Uncoupling Intensive Insulin Therapy from Weight Gain and Hypoglycemia in Type 1 Diabetes.
  236. Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects.
  237. Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes.
  238. Lowering Postprandial Glycemia in Children with Type 1 Diabetes After Italian Pizza "Margherita" (TyBoDi2 Study). Compare result with Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system
  239. A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes.
  240. The relation of age to the severity of Type I diabetes in children. Free full text available in HTML and PDF formats.
  241. Effects of Carbohydrate Counting on Glucose Control and Quality of Life Over 24 Weeks in Adult Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
  242. A psychological support program for individuals with Type 1 diabetes.

    2 March 2011

  243. Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes.
  244. Risk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection.

    23 February 2011

  245. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.
  246. Easily Missed? Type 1 diabetes in children.
  247. Perceptions of parenting children with type 1 diabetes diagnosed in early childhood.
  248. Sugars and fat have different effects on postprandial glucose responses in normal and type 1 diabetic subjects.
  249. Endurance Athletes and Type 1 Diabetes.
  250. Effects of a home-based aerobic exercise programme in children with type 1 diabetes mellitus.
  251. A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 Diabetes.

    16 February 2011

  252. How continuous monitoring changes the interaction of patients with a mobile telemedicine system.
  253. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart Algorithm, a 1-Hour Warm-Up Time.
  254. Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia.
  255. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.
  256. Deprivation impedes success of insulin intensification in children and adolescents with Type 1 diabetes; longitudinal linear mixed modelling of a retrospective observational cohort.
  257. Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries.
  258. The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality In Patients With Type 1 Diabetes.
  259. Diagnostic Accuracy of Point-of-Care Testing for Diabetic Ketoacidosis at Emergency-Department Triage; beta-hydroxybutyrate versus the urine dipstick.

    9 February 2011

  260. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes shows the benefit of using the insulin pump bolus calculation function.
  261. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
  262. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study.
  263. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
  264. Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood.
  265. Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes.
  266. Social but safe? Quality and safety of diabetes-related online social networks.
  267. Adolescent self-efficacy and resilience in participants attending a diabetes camp.
  268. Parent mentor perspectives on providing social support to empower parents.
  269. Declining prevalence of proliferative retinopathy in patients with type 1 diabetes.
  270. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
  271. Clinical presentation and autoimmune characteristics of very young children at the onset of type 1 diabetes mellitus.
  272. The outcome of brittle type 1 diabetes--a 20 year study.

    2 February 2011

  273. Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy.
  274. Insufficient Sleep in Young Patients With Diabetes and Their Families.
  275. Frequency and Influencing Factors of Ketoacidosis at Diabetes Onset in Children and Adolescents - a Long-Term Study Between 1995 and 2009.
  276. Glucose Monitoring After Fruit Peeling: Pseudohyperglycemia When Neglecting Hand Washing Before Fingertip Blood Sampling; Wash your hands with tap water before you check blood glucose level.
  277. The utility of hemoglobin A1c at diagnosis for prediction of future glycemic control in children with type 1 diabetes.
  278. Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 Diabetes Mellitus.
  279. Celiac Disease and Autoimmune Thyroid Disease in Children with Type 1 Diabetes Mellitus: Clinical and HLA-Genotyping Results.
  280. Growth of children with type 1 diabetes mellitus.
  281. Insulin Degludec in Type 1 Diabetes; A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

    26 January 2011

  282. Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States.
  283. Hemoglobin A1c and Mean Glucose in Patients With Type 1 Diabetes.
  284. How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients' self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course.
  285. Sugar-sweetened and diet beverage consumption is associated with cardiovascular risk factor profile in youth with type 1 diabetes.

    19 January 2011

  286. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion.
  287. Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart.
  288. Impact of pre-exercise rapid-acting insulin reductions on ketogenesis following running in Type 1 diabetes.
  289. Exercise training improves physical fitness and vascular function in children with type 1 diabetes.
  290. Web-Based Depression Treatment for Type 1 and Type 2 Diabetic Patients.
  291. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
  292. Declining prevalence of proliferative retinopathy in patients with type 1 diabetes. Free full text available in HTML and PDF formats.
  293. QT Measurement and Heart Rate Correction during Hypoglycemia: Is There a Bias? Free full text available in HTML and PDF formats.
  294. Birth weight in type 1 diabetic pregnancy. Free full text available in HTML and PDF formats.
  295. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials.

    12 January 2011

  296. Maternal communication style, problem-solving and dietary adherence in young children with type 1 diabetes.
  297. Insulin dose changes in children attending a residential diabetes camp.
  298. The effect of oral leucine on protein metabolism in adolescents with type 1 diabetes mellitus. Free full text available in HTML and PDF formats.
  299. New technologies in pediatric diabetes care.
  300. Nurse-led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance.

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:57
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.